Results 61 to 70 of about 4,121 (173)
Arthritis Care &Research, Volume 78, Issue 1, Page 85-95, January 2026.Objective Axial spondyloarthritis (axSpA) is often associated with persistent pain despite effective anti‐inflammatory treatment. Digital health applications (DHAs) provide innovative approaches to address multidimensional aspects of persistent pain through psychological and behavioral strategies. The aim of this study was to assess the impact of a DHA
David Kiefer +7 more
wiley +1 more source
Archives of Nursing Research, 2019 La Espondilitis Anquilosante es una patología inflamatoria, crónica y degenerativa de lasarticulaciones. Afecta mayormente a la columna vertebral y a la articulación sacroilíaca.
Alba Torres Pérez
doaj +7 more sources
Arthritis &Rheumatology, Volume 78, Issue 1, Page 26-36, January 2026.Objective To identify and summarize existing telerehabilitation interventions for people living with rheumatic and musculoskeletal diseases (RMDs), including the rehabilitation components, the technology used, the type of health care professional (HCP) interaction, and how the effectiveness is evaluated.
Thomas A. Ingram +5 more
wiley +1 more source
AB0865 Do asas, asdas and basdai therapy response evaluation translate the same information? [PDF]
Annals of the Rheumatic Diseases, 2018 Background The ASAS-EULAR recommendations for the continuation of biological Disease-Modifying Anti-rheumatic Drugs (DMARD) suggest the evaluation of patients after at least 12 weeks of treatment by either the Ankylosing Spondylitis (AS) Disease Activity Score – C reactive protein (ASDAS-CRP) or by the Bath AS Disease Activity Index (BASDAI).
M. Eusébio +13 more
openaire +1 more source
Case Reports in Rheumatology, Volume 2026, Issue 1, 2026.Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by autoantibody production and immune complex deposition. Antiphospholipid syndrome (APS) is frequently associated with SLE and is characterized by arterial or venous thrombosis and pregnancy morbidity in the presence of persistent antiphospholipid antibodies.
Enes Basaran +5 more
wiley +1 more source
International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.Objectives To determine the level of dysfunctional high‐density lipoprotein (dHDL) with the myeloperoxidase/paraoxonase‐1 (MPO/PON‐1) ratio and its relationship with epicardial adipose tissue thickness (EATT) in patients with ankylosing spondylitis (AS).
Yagmur Cagla Reis Altan +5 more
wiley +1 more source
Arthritis Research & Therapy, 2023 Background The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement.
Xenofon Baraliakos +12 more
doaj +1 more source
Arthritis Care &Research, Volume 77, Issue 12, Page 1443-1452, December 2025.Objective Imaging evidence of active sacroiliitis is important for diagnosis, classification, and monitoring of axial spondyloarthritis (axSpA). However, there is no consistent guidance on whether patients should temporarily stop nonsteroidal anti‐inflammatory drugs (NSAIDs) before magnetic resonance imaging (MRI).
Gareth T. Jones +10 more
wiley +1 more source
Immunity, Inflammation and Disease, Volume 13, Issue 12, December 2025.ABSTRACT Background Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the axial skeleton causing pain, inflammation, and stiffness. Individuals with axSpA are at greater risk of developing cardiovascular disease, which can be counteracted by physical activity. High‐intensity interval training (HIIT) has been shown to
Åsa Andersson +4 more
wiley +1 more source
International Journal of Dermatology, Volume 64, Issue 11, Page 2038-2044, November 2025.ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola +12 more
wiley +1 more source